Oscar D’Agnone

403 total citations
15 papers, 296 citations indexed

About

Oscar D’Agnone is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Anesthesiology and Pain Medicine. According to data from OpenAlex, Oscar D’Agnone has authored 15 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 6 papers in Pharmacology and 6 papers in Anesthesiology and Pain Medicine. Recurrent topics in Oscar D’Agnone's work include Opioid Use Disorder Treatment (10 papers), Pain Management and Opioid Use (6 papers) and Substance Abuse Treatment and Outcomes (5 papers). Oscar D’Agnone is often cited by papers focused on Opioid Use Disorder Treatment (10 papers), Pain Management and Opioid Use (6 papers) and Substance Abuse Treatment and Outcomes (5 papers). Oscar D’Agnone collaborates with scholars based in United Kingdom, Germany and Finland. Oscar D’Agnone's co-authors include Richard Littlewood, Hannu Alho, Icro Maremmani, Lorenzo Somaini, Peter Krajči, Jens Reimer, Nat Wright, Carlos Roncero, Maurice Demattéis and Marta Torrens and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Gastroenterology & Hepatology and Journal of Public Health.

In The Last Decade

Oscar D’Agnone

14 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oscar D’Agnone United Kingdom 8 199 145 63 52 46 15 296
Thilo Beck Switzerland 10 190 1.0× 178 1.2× 89 1.4× 31 0.6× 37 0.8× 12 360
Alain Masut France 8 249 1.3× 132 0.9× 55 0.9× 38 0.7× 58 1.3× 9 341
Sreedevi Vayalapalli United States 12 304 1.5× 254 1.8× 74 1.2× 71 1.4× 90 2.0× 16 504
Alfonso Ang United States 8 204 1.0× 184 1.3× 45 0.7× 45 0.9× 74 1.6× 10 336
Meng-Fan Su China 5 232 1.2× 195 1.3× 25 0.4× 28 0.5× 77 1.7× 6 321
Denis Antoine United States 12 210 1.1× 138 1.0× 98 1.6× 67 1.3× 44 1.0× 33 415
Arild Opheim Norway 8 282 1.4× 231 1.6× 54 0.9× 51 1.0× 77 1.7× 17 354
Mirsada Serdarevic United States 7 197 1.0× 97 0.7× 59 0.9× 60 1.2× 97 2.1× 15 335
Kristin Klemmetsby Solli Norway 10 329 1.7× 265 1.8× 61 1.0× 62 1.2× 83 1.8× 30 406
Richard Hallinan Australia 11 145 0.7× 157 1.1× 53 0.8× 53 1.0× 59 1.3× 14 439

Countries citing papers authored by Oscar D’Agnone

Since Specialization
Citations

This map shows the geographic impact of Oscar D’Agnone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oscar D’Agnone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oscar D’Agnone more than expected).

Fields of papers citing papers by Oscar D’Agnone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oscar D’Agnone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oscar D’Agnone. The network helps show where Oscar D’Agnone may publish in the future.

Co-authorship network of co-authors of Oscar D’Agnone

This figure shows the co-authorship network connecting the top 25 collaborators of Oscar D’Agnone. A scholar is included among the top collaborators of Oscar D’Agnone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oscar D’Agnone. Oscar D’Agnone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Maremmani, Icro, Norbert Scherbaum, Marc Auriacombe, et al.. (2021). Early-readmission after Agonist Opioid Treatment in five European countries. A drug addiction health policy challenge?. 23(4). 69–79. 3 indexed citations
2.
Parsons, G., et al.. (2020). Patient-Reported Outcomes, Experiences and Satisfaction with Weekly and Monthly Injectable Prolonged-Release Buprenorphine. SHILAP Revista de lepidopterología. 1 indexed citations
3.
Gottschling, Sven, et al.. (2020). Safety Considerations in Cannabinoid-Based Medicine. SHILAP Revista de lepidopterología. 4 indexed citations
4.
Gottschling, Sven, Oyedeji Ayonrinde, Arun Bhaskar, et al.. (2020). <p>Safety Considerations in Cannabinoid-Based Medicine</p>. International Journal of General Medicine. Volume 13. 1317–1333. 31 indexed citations
5.
D’Agnone, Oscar, et al.. (2020). <p>Patient-Reported Outcomes, Experiences and Satisfaction with Weekly and Monthly Injectable Prolonged-Release Buprenorphine</p>. PubMed. Volume 11. 41–47. 24 indexed citations
6.
Kraus, M., Nicholas Lintzeris, Arun Bhaskar, et al.. (2019). Consensus and Controversies Between Pain and Addiction Experts on the Prevention, Diagnosis, and Management of Prescription Opioid Use Disorder. Journal of Addiction Medicine. 14(1). 1–11. 36 indexed citations
7.
D’Agnone, Oscar. (2019). Successful Treatment of Opioid Dependence with Flexible Doses of Injectable Prolonged Release Buprenorphine. SHILAP Revista de lepidopterología. 2019. 1–4. 4 indexed citations
8.
Wright, Nat, Jens Reimer, Lorenzo Somaini, et al.. (2017). Are we ready to treat hepatitis C virus in individuals with opioid use disorder: assessment of readiness in European countries on the basis of an expert-generated model. European Journal of Gastroenterology & Hepatology. 29(11). 1206–1214. 11 indexed citations
9.
Demattéis, Maurice, Marc Auriacombe, Oscar D’Agnone, et al.. (2017). Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus. Expert Opinion on Pharmacotherapy. 18(18). 1987–1999. 94 indexed citations
10.
Maremmani, Icro, Benjamin Rolland, Lorenzo Somaini, et al.. (2016). Buprenorphine dosing choices in specific populations: review of expert opinion. Expert Opinion on Pharmacotherapy. 17(13). 1727–1731. 14 indexed citations
11.
Reimer, Jens, Nat Wright, Lorenzo Somaini, et al.. (2015). The Impact of Misuse and Diversion of Opioid Substitution Treatment Medicines: Evidence Review and Expert Consensus. European Addiction Research. 22(2). 99–106. 29 indexed citations
12.
Alho, Hannu, Oscar D’Agnone, Peter Krajči, et al.. (2015). The extent of misuse and diversion of medication for agonist opioid treatment: A review and expert opinions. 17. 25–34. 6 indexed citations
13.
Wright, Nat, Oscar D’Agnone, Peter Krajči, et al.. (2015). Addressing misuse and diversion of opioid substitution medication: guidance based on systematic evidence review and real-world experience. Journal of Public Health. 38(3). e368–e374. 31 indexed citations
14.
D’Agnone, Oscar. (2015). What have we learned and what can we do about NPS?. Drugs and Alcohol Today. 15(1). 28–37. 4 indexed citations
15.
D’Agnone, Oscar, et al.. (1989). Some familial dynamic aspects in drug abusers.. PubMed. 8(5). 431–2. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026